Savara (SVRA) Profit After Tax (2010 - 2026)

Savara's (SVRA) quarterly Profit After Tax came in at -$37.3 million in Q1 2026, down 39.96% year-on-year from -$62.1 million in Q1 2025, and down 15.66% on a QoQ basis from -$32.2 million in Q4 2025.

Savara (SVRA) Profit After Tax (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Profit After Tax data on file, last reported at -$37.3 million in Q1 2026.

  • On a quarterly basis, Profit After Tax fell 39.96% year-over-year to -$37.3 million in Q1 2026; TTM through Mar 2026 was -$129.5 million, a 26.73% decrease from a year earlier, with the FY2025 full-year figure at -$118.8 million, down 23.94% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$37.3 million, down from -$32.2 million in the prior quarter.
  • Over the last five years, Profit After Tax for SVRA reached as high as -$8.3 million in Q1 2022 and fell as low as -$37.3 million in Q1 2026.
  • Historically, Profit After Tax has averaged -$20.3 million across 5 years, with a median of -$20.3 million in 2024.
  • Across the five-year window, Profit After Tax rose 18.76% in 2022 and tumbled 94.38% in 2024, its largest moves.
  • Year by year, Profit After Tax stood at -$10.3 million in 2022, then tumbled by 53.03% to -$15.8 million in 2023, then sank by 84.27% to -$29.0 million in 2024, then declined by 10.99% to -$32.2 million in 2025, then dropped by 15.66% to -$37.3 million in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were -$37.3 million in Q1 2026, -$32.2 million in Q4 2025, and -$29.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Savara 1.24 Bn 1.24 Bn - -37.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -37.28 Mn
Dec 31, 2025 -32.24 Mn
Sep 30, 2025 -29.56 Mn
Jun 30, 2025 -30.40 Mn
Mar 31, 2025 -26.64 Mn
Dec 31, 2024 -29.04 Mn
Sep 30, 2024 -24.25 Mn
Jun 30, 2024 -22.24 Mn
Mar 31, 2024 -20.35 Mn
Dec 31, 2023 -15.76 Mn
Sep 30, 2023 -16.60 Mn
Jun 30, 2023 -11.44 Mn
Mar 31, 2023 -10.56 Mn
Dec 31, 2022 -10.30 Mn
Sep 30, 2022 -10.39 Mn
Jun 30, 2022 -9.16 Mn
Mar 31, 2022 -8.30 Mn
Dec 31, 2021 -11.31 Mn
Sep 30, 2021 -10.85 Mn
Jun 30, 2021 -10.94 Mn